Nicotine Addiction Substance Abuse Opioid Addiction Smoking Harm Reduction Drug Policy Tobacco Use Tobacco Addiction Opioid Crisis Alcoholism Substance Use Opioid Epidemic Crisis Management Prescription Drugs Social Impact Public Awareness Drug Overdose Gambling Opioid Use Human Rights Mental Health Patient Care Community Impact Substance Use Disorders Drug Use Nikotinsucht Public Perception Impact on Families Pharmaceutical Industry Smoking-Related Diseases Recovery Support Cocaine Addiction Nicotine Dependence Treatment Access Chemsex Alcohol Abuse Smoking Cessation
Manufacturers must file new labels within 30 days with numerical estimates of long-term opioid harms.